Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut
By Arasu Kannagi Basil (Reuters) -MapLight Therapeutics debuted on the Nasdaq on Monday with a valuation of $787 million, becoming ...
Tag: regulatory provision
By Arasu Kannagi Basil (Reuters) -MapLight Therapeutics debuted on the Nasdaq on Monday with a valuation of $787 million, becoming ...
